Indraprastha Medical Corporation growth over the years

·Pharma & HealthChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Compounded a year1 yr3 yr
Revenue+9.3%+10.5%
EBITDA+9.3%+21.0%
Net Income+14.1%+28.7%
EPS (adj.)+14.1%+28.7%
Total Assets+16.4%+21.3%
Total Equity+24.1%+25.0%
Free Cash Flow−10.5%+2.6%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

INDRAMEDCO₹300.00

Indraprastha Medical Corporation Limited

· Pharma & Health
₹ CrorePeersARTEMISMEDSHALBYGKSLGPTHEALTHLOTUSEYEDRAGARWQKMCSHILKOVAIMcap ₹2,750 Cr
Annuals · FY-end closes
Compounded Growth
Annuals · CAGR %
1Y
CAGR
3Y
CAGR
Revenue+9.3+10.5
EBITDA+9.3+21.0
Net Income+14.1+28.7
EPS (adj.)+14.1+28.7
Total Assets+16.4+21.3
Total Equity+24.1+25.0
Free Cash Flow-10.5+2.6
CAGR from filed annuals — needs positive start & end values.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.